HERMIONE: a randomized Phase 2 trial of MM-302 plus trastuzumab versus chemotherapy of physician's choice plus trastuzumab in patients with previously treated, anthracycline-naïve, HER2-positive, locally advanced/metastatic breast cancer.
about
Therapeutic targeting in nanomedicine: the future lies in recombinant antibodies.Advances in systemic therapy for metastatic breast cancer: future perspectives.Development and clinical application of anti-HER2 monoclonal and bispecific antibodies for cancer treatment.Current Therapies for Human Epidermal Growth Factor Receptor 2-Positive Metastatic Breast Cancer Patients.ScFvs as Allosteric Inhibitors of VEGFR-2: Novel Tools to Harness VEGF Signaling.Tribody [(HER2)2xCD16] Is More Effective Than Trastuzumab in Enhancing γδ T Cell and Natural Killer Cell Cytotoxicity Against HER2-Expressing Cancer Cells.All-trans retinoic acid-encapsulated, CD20 antibody-conjugated poly(lactic--glycolic acid) nanoparticles effectively target and eliminate melanoma-initiating cells in vitroClinical Potential of Human Epidermal Growth Factor Receptor 2 and Human Epidermal Growth Factor Receptor 3 Imaging in Breast CancersiRNA-encapsulated immunoliposomes conjugated with CD44 antibodies target and eliminate gastric cancer-initiating cells
P2860
Q38658279-AC1533F0-D82C-44E6-8CB3-8078CFDD947FQ38681576-B238E316-D62B-455B-B6D4-45782B748610Q47103332-A675A362-4575-4444-A05F-A567E33A6C65Q52578959-4AAE2D94-3F2A-4883-95C1-3CB6F4636BDCQ54112592-DF802232-0F3C-4EF0-909B-C55F6A352177Q55240690-9D13F86A-BD3B-4A85-AA71-F8101944262AQ57069994-6B3C9DCE-D7C1-4343-B160-D8680AB47F7DQ57110662-ABCCD8BC-E0B1-4CE5-B55B-6C2101644472Q57816012-E5EBF3A8-17B8-4105-BA80-0640BB779626
P2860
HERMIONE: a randomized Phase 2 trial of MM-302 plus trastuzumab versus chemotherapy of physician's choice plus trastuzumab in patients with previously treated, anthracycline-naïve, HER2-positive, locally advanced/metastatic breast cancer.
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
2016年论文
@zh
2016年论文
@zh-cn
name
HERMIONE: a randomized Phase 2 ...... nced/metastatic breast cancer.
@ast
HERMIONE: a randomized Phase 2 ...... nced/metastatic breast cancer.
@en
type
label
HERMIONE: a randomized Phase 2 ...... nced/metastatic breast cancer.
@ast
HERMIONE: a randomized Phase 2 ...... nced/metastatic breast cancer.
@en
prefLabel
HERMIONE: a randomized Phase 2 ...... nced/metastatic breast cancer.
@ast
HERMIONE: a randomized Phase 2 ...... nced/metastatic breast cancer.
@en
P2093
P2860
P1433
P1476
HERMIONE: a randomized Phase 2 ...... nced/metastatic breast cancer.
@en
P2093
Debu Tripathy
Denise A Yardley
Ian E Krop
Istvan Molnar
Joseph G Reynolds
Kathy Miller
Kaveh Riahi
Sara A Hurvitz
Sunil Verma
Thomas J Wickham
P2860
P2888
P356
10.1186/S12885-016-2385-Z
P407
P577
2016-06-03T00:00:00Z
P6179
1020233811